Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;19(8):2210-2218.
doi: 10.1111/ajt.15353. Epub 2019 Apr 5.

Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation

Affiliations

Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation

Neil Mehta et al. Am J Transplant. 2019 Aug.

Abstract

All patients with hepatocellular carcinoma meeting United Network for Organ Sharing T2 criteria currently receive the same listing priority for liver transplant (LT). A previous study from our center identified a subgroup with a very low risk of waitlist dropout who may not derive immediate LT benefit. To evaluate this issue at a national level, we analyzed within the United Network for Organ Sharing database 2052 patients with T2 hepatocellular carcinoma receiving priority listing from 2011 to 2014 in long wait time regions 1, 5, and 9. Probabilities of waitlist dropout were 18.3% at 1 year and 27% at 2 years. In multivariate analysis, factors associated with a lower risk of waitlist dropout included Model for End-Stage Liver Disease-Na < 15, Child's class A, single 2- to 3-cm lesion, and α-fetoprotein ≤20 ng/mL. The subgroup of 245 (11.9%) patients meeting these 4 criteria at LT listing had a 1-year probability of dropout of 5.5% vs 20% for all others (P < .001). On explant, the low dropout risk group was more likely to have complete tumor necrosis (35.5% vs 24.9%, P = .01) and less likely to exceed Milan criteria (9.9% vs 17.7%, P = .03). We identified a subgroup with a low risk of waitlist dropout who should not receive the same LT listing priority.

Keywords: Organ Procurement and Transplantation Network (OPTN); United Network for Organ Sharing (UNOS); clinical research/practice; health services and outcomes research; liver disease malignant; liver transplantation/hepatology; organ allocation; organ procurement and allocation; recipient selection.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.

Figures

FIGURE 1
FIGURE 1
Cumulative incidence of liver transplant (LT) and waitlist dropout due to tumor progression, being too sick to undergo LT, or death
FIGURE 2
FIGURE 2
Cumulative incidence of waitlist dropout due to tumor progression, being too sick to undergo livertransplant, or death by listing characteristics. A, MELD-Na < 15 vs ≥ 15. B, Child-Pugh class. C, Tumor size. D, α-Fetoprotein ≤20 vs >20 ng/mL
FIGURE 3
FIGURE 3
Cumulative incidence of waitlist dropout with low-risk group meeting all of the following at listing: MELD-Na < 15, Child-Pugh class A, single tumor 2–3 cm, and AFP ≤20 ng/mL

Comment in

References

    1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. - PubMed
    1. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology. 2017;152(4):812–820 e5. - PMC - PubMed
    1. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014;59(6):2188–2195. - PubMed
    1. Mehta N, Dodge J, Hirose R, Roberts JP, Yao FY. Increasing liver transplant waitlist dropout for hepatocellular carcinoma with widening geographical disparities. Am J Transplant. 2017;17(suppl S3):212–213. - PMC - PubMed
    1. Massie AB, Caffo B, Gentry SE, et al. MELD exceptions and rates of waiting list outcomes. Am J Transplant. 2011;11(11):2362–2371. - PMC - PubMed

Publication types

MeSH terms